Showing results (941-950 of 5,269) with videos related to
Sort By:
Pageof 527
European Journal of Haematology|July 1, 1987
Neutrophil dysfunctions in thalassaemia major: the role of cell iron overloadB Cantinieaux, C Hariga, A Ferster, et al.European Journal of Haematology|July 1, 1987
The effect of an isoprenaline infusion on the splenic blood flow and intrasplenic platelet kineticsH Wadenvik, J KuttiEuropean Journal of Haematology|December 19, 2022
Long-term outcomes of aplastic anemia with cytogenetic abnormalities at diagnosisJianping Li, Xu Liu, Xin Zhao, et al.European Journal of Haematology|December 1, 2022
Effective T-cell replete haploidentical stem cell transplantation for pediatric patients with high-risk hematologic disordersSupavich Tannumsaeung, Usanarat Anurathapan, Samart Pakakasama, et al.European Journal of Haematology|May 9, 2022
Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long-term prophylaxis: An expert opinion paper from an Italian panelGiancarlo Castaman, Alessandra Borchiellini, Antonio Coppola, et al.European Journal of Haematology|May 9, 2022
Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft-versus-host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI-based allogeneic hematopoietic cell transplantationLeonardo Javier Arcuri, Decio Lerner, Rita de Cassia Barbosa da Silva TavaresEuropean Journal of Haematology|April 6, 2020
Thioredoxin-1 as a biological predictive marker for selecting diffuse large B-cell lymphoma patients for etoposide-containing treatmentEsa Jarkko Mikael Kari, Milla Elvi Linnea Kuusisto, Päivi Honkavaara, et al.European Journal of Haematology|September 29, 2020
Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic-phase CML in clinical practice: 3-year European SIMPLICITY dataCarlo Gambacorti-Passerini, Clara Chen, Catherine Davis, et al.European Journal of Haematology|September 30, 2020
Targeting both BET and CBP/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti-tumor activity in multiple myelomaKatie R Ryan, Francis Giles, Gareth J MorganEuropean Journal of Haematology|December 3, 2020
The hematologic consequences of obesityJohanna C Purdy, Joseph J ShatzelPageof 527